Back

Imaging innovations for diagnosis, risk, and therapy in transthyretin amyloidosis - discussion

28 August 2026 (11:48 - 12:00)
Organised by: Logo
Congress Presentation Part of: Imaging innovations for diagnosis, risk, and therapy in transthyretin amyloidosis Imaging of Myocardial Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

4 More presentations in this session

Presentation thumbnail
Novel tracers to improve transthyretin amyloidosis diagnostics
Doctor S. Dorbala (Boston, US)
Slides Video
Presentation thumbnail
Imaging-guided risk stratification in transthyretin amyloidosis
Doctor K. Jering (Boston, US)
Slides Video
Presentation thumbnail
Therapy selection based on imaging
Professor M. Pieroni (Florence, IT)
Slides Video
Presentation thumbnail
Monitoring transthyretin amyloidosis diseases using imaging
Doctor M. Hundertmark (Bern, CH)
Slides Video

Access the full session

Session thumbnail
Imaging innovations for diagnosis, risk, and therapy in transthyretin amyloidosis
Video

The Event

Event poster

ESC Congress 2026

28 August 2026 11:48 CET
You may be interested in
thumbnail
Congress Presentation
Future perspectives: novel tracers, tracking disease progression, and response to therapy
11 December 2025
thumbnail
Congress Presentation
Imaging in cardiac amyloidosis: from diagnosis to diseases monitoring - discussion
30 August 2025
thumbnail
Congress Presentation
Discussion and closing remarks
11 May 2023
thumbnail
Congress Session
Cardiac imaging for ATTR-CM: the key to raising suspicion and monitoring disease
11 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources